ARTICLE | Company News
Neurogen, Sanofi-Aventis ending CRF1 deal
September 15, 2004 7:00 AM UTC
NRGN and Sanofi- Aventis S.A. (Euronext:SAN; SNY) will terminate on Dec. 8 their 2001 deal to develop therapeutics against corticotrophin releasing factor ( CRF1) for stress disorders, including depre...